Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome

Summary

This randomized pilot clinical trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being studied to see if it will decrease pain following paclitaxel.

Timeline

Start

2014-02-19

Primary completion

2015-11-11

Completion

2016-11-11

Drugs

Indications

No indication recorded.